Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Molecular Targets For Therapy (MTT)
  • Published:

Molecular Targets for Therapy (MTT)

Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro

Leukemia volume 17, pages 1294–1300 (2003)Cite this article

Abstract

Stromal cell-derived factor-1 (SDF-1) is a key regulator of the behavior of normal and leukemic precursor-B (pre-B) cells. It is possible that inhibiting SDF-1-driven processes in pre-B acute lymphoblastic leukemia (ALL) may have therapeutic implications. In this study, we examined the ability of SDF-1 inhibitors to modulate pre-B ALL cell responses to SDF-1, including chemotaxis, migration into bone marrow stroma, and stroma-supported survival and proliferation on human bone marrow stromal layers. The polyphemusin II-derived inhibitors, T140, TC140012, and T134, and the bicyclam AMD3100, effectively inhibited binding of the anti-CXCR4 monoclonal antibody 12G5 on the pre-B ALL cell line NALM6, with IC50 values of 0.9, 0.9, 0.9, and 1.9 nM, respectively. Similar results were obtained with ALL samples. T140 (0.1 μ M) and AMD3100 (1 μ M) completely blocked SDF-1-induced chemotaxis and attenuated the migration of pre-B ALL cells into bone marrow stromal layers. AMD3100 and TC140012 at a concentration of 50 μ M significantly inhibited stroma-dependent proliferation of six and four of the eight cases tested, respectively, without reducing the cell viability. In addition, AMD3100 and TC140012 enhanced the cytotoxic and antiproliferative effects of the cytotoxic agents vincristine and dexamethasone. The ability of SDF-1 inhibitors to modulate these biologically important functions of leukemic cells warrants further investigation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  1. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370–2377.

    CAS  PubMed  Google Scholar 

  2. Bradstock K, Makrynikola V, Bianchi A, Byth K . Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts. Blood 1993; 82: 3437–3444.

    CAS  PubMed  Google Scholar 

  3. Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN . Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112–121.

    CAS  PubMed  Google Scholar 

  4. Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ . Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 2000; 14: 882–888.

    Article  CAS  PubMed  Google Scholar 

  5. Nagasawa T, Kikutani H, Kishimoto T . Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 1994; 91: 2305–2309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635–638.

    Article  CAS  PubMed  Google Scholar 

  7. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR . Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595–599.

    Article  CAS  PubMed  Google Scholar 

  8. Shen W, Bendall LJ, Gottlieb DJ, Bradstock KF . The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp Hematol 2001; 29: 1439–1447.

    Article  CAS  PubMed  Google Scholar 

  9. Nishii K, Katayama N, Miwa H, Shikami M, Masuya M, Shiku H et al. Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein. Br J Haematol 1999; 105: 701–710.

    Article  CAS  PubMed  Google Scholar 

  10. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I . N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 1998; 273: 22279–22283.

    Article  CAS  PubMed  Google Scholar 

  11. Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H et al. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 1997; 186: 1389–1393.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Tamamura H, Arakaki R, Funakoshi H, Imai M, Otaka A, Ibuka T et al. Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22, ([Tyr5, 12, Lys7]-polyphemusin II). Bioorg Med Chem 1998; 6: 231–238.

    Article  CAS  PubMed  Google Scholar 

  13. Schols D, Struyf S, Van Damme J, Este JA, Henson G, De Clercq E . Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186: 1383–1388.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 2000; 44: 1667–1673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bendall LJ, Kortlepel K, Gottlieb DJ . Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood 1993; 82: 3125–3132.

    CAS  PubMed  Google Scholar 

  16. Makrynikola V, Bianchi A, Bradstock K, Gottlieb D, Hewson J . Migration of acute lymphoblastic leukemia cells into human bone marrow stroma. Leukemia 1994; 8: 1734–1743.

    CAS  PubMed  Google Scholar 

  17. De Clercq E . Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists. Mol Pharmacol 2000; 57: 833–839.

    CAS  PubMed  Google Scholar 

  18. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000; 96: 2655–2663.

    CAS  PubMed  Google Scholar 

  19. Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 2001; 167: 4686–4692.

    Article  CAS  PubMed  Google Scholar 

  20. Murphy PM . Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001; 345: 833–835.

    Article  CAS  PubMed  Google Scholar 

  21. D'Apuzzo M, Rolink A, Loetscher M, Hoxie JA, Clark-Lewis I, Melchers F et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol 1997; 27: 1788–1793.

    Article  CAS  PubMed  Google Scholar 

  22. Fedyk ER, Ryyan DH, Ritterman I, Springer TA . Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). J Leukocyte Biol 1999; 66: 667–673.

    Article  CAS  PubMed  Google Scholar 

  23. Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE . SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 1999; 94: 2990–2998.

    CAS  PubMed  Google Scholar 

  24. Voermans C, Anthony EC, Mul E, van der Schoot E, Hordijk P . SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells. Exp Hematol 2001; 29: 1456–1464.

    Article  CAS  PubMed  Google Scholar 

  25. Lee Y, Gotoh A, Kwon HJ, You M, Kohli L, Mantel C et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 2002; 99: 4307–4317.

    Article  CAS  PubMed  Google Scholar 

  26. Tamamura H, Omagari A, Hiramatsu K, Gotoh K, Kanamoto T, Xu Y et al. Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. Bioorg Med Chem Lett 2001; 11: 1897–1902.

    Article  CAS  PubMed  Google Scholar 

  27. Datema R, Rabin L, Hincenbergs M, Moreno MB, Warren S, Linquist V et al. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother 1996; 40: 750–754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ . AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol 2002; 160: 1353–1360.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by a Faculty of Medicine/Medical Foundation Postgraduate Research Scholarship from the University of Sydney and the Anthony Rothe Memorial Trust. AnorMED Inc. (Canada) generously provided AMD3100. We are grateful to Karren Byth for statistical advice and to Dr Sylvie Shen for her guidance and support.

Author information

Authors and Affiliations

  1. Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Australia

    J Juarez & L J Bendall

  2. Department of Hematology Westmead Hospital, Australia

    K F Bradstock

  3. Department of Medicine, University of Sydney, Australia

    D J Gottlieb

Authors
  1. J Juarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K F Bradstock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D J Gottlieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L J Bendall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juarez, J., Bradstock, K., Gottlieb, D. et al. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 17, 1294–1300 (2003). https://doi.org/10.1038/sj.leu.2402998

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402998

Keywords

This article is cited by

Search

Advanced search

Quick links